Greenberg Traurig’s David Dykeman and Win Rutherfurd Present at DeviceTalks Boston

BOSTON - June 4, 2026 - David J. Dykeman, co-chair of the Life Sciences & Medical Technology Group of global law firm Greenberg Traurig, LLP, and Win Rutherfurd, a shareholder in the firm's Capital Markets Practice, presented on the DeviceTalks Boston panel, "Positioning IP for Funding & Exits," May 27.

The panel explored strategies that medical technology companies can use to strengthen intellectual property portfolios, attract investors, and position themselves for successful financing transactions, mergers and acquisitions, or initial public offerings (IPOs). Panelists discussed common pitfalls to avoid, how companies can build competitive patent portfolios, and approaches for enhancing valuation and market positioning. Dykeman and Rutherfurd were joined by Jed Cohen, managing director, Medical Technology Investment Banking at Raymond James, and Irina Ridley, chief legal officer at Aerin Medical.

In connection with the conference, Greenberg Traurig hosted a networking reception May 26 in the firm's Boston office for attendees of DeviceTalks and the Robotics Summit & Expo.

Dykeman, co-managing shareholder of Greenberg Traurig's Boston office, is a registered patent attorney focused on securing worldwide intellectual property protection and related business strategies for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. He provides strategic patent portfolio development and intellectual property advice for clients, including major research institutions, multinational corporations, and startup companies. He serves on the board of directors of MassMEDIC and previously served on the editorial advisory board for Medical Device & Diagnostic Industry magazine. Dykeman was named "Massachusetts Patent Strategy Attorney of the Year" by LMG Life Sciences in 2022.

Rutherfurd advises public and pre-IPO companies on capital markets and corporate governance matters and compliance with securities laws. He represents issuers in a range of financing transactions, including equity and debt offerings, liability management, and private placements, including in the area of real estate investment trusts. He also advises clients on a wide variety of securities laws and governance matters, including drafting and reviewing annual, periodic, and current reports and proxy statements, compliance with SEC/stock exchange rules, and board meeting minutes, as well as with respect to day-to-day operational matters, including contract review, covenant compliance, internal restructurings, intercompany arrangements, and investor communications.